Title:
ORAL PHARMACEUTICAL COMPOSITION CONTAINING HETEROCYCLIC COMPOUND
Document Type and Number:
WIPO Patent Application WO/2021/029430
Kind Code:
A1
Abstract:
The present invention provides a means that can prevent excessive release of an active ingredient at an initial stage and that is capable of releasing the active ingredient in a sustained manner over a long period of time at a therapeutic effective dose.
More Like This:
Inventors:
YOSHIMURA MOTOYASU (JP)
FUJII TAKUYA (JP)
KAMADA NAOKI (JP)
TOGASHI RYOHEI (JP)
AONO RYUTA (JP)
WANG XINYU (JP)
FUJII TAKUYA (JP)
KAMADA NAOKI (JP)
TOGASHI RYOHEI (JP)
AONO RYUTA (JP)
WANG XINYU (JP)
Application Number:
PCT/JP2020/030777
Publication Date:
February 18, 2021
Filing Date:
August 13, 2020
Export Citation:
Assignee:
OTSUKA PHARMA CO LTD (JP)
International Classes:
A61K47/38; A61K31/496
Domestic Patent References:
WO2013054872A1 | 2013-04-18 |
Foreign References:
JP2014510023A | 2014-04-24 | |||
JP2008115172A | 2008-05-22 | |||
CN106667969A | 2017-05-17 | |||
JP2006316052A | 2006-11-24 | |||
US3173876A | 1965-03-16 | |||
US3276586A | 1966-10-04 | |||
US3541005A | 1970-11-17 | |||
US3541006A | 1970-11-17 | |||
US3546142A | 1970-12-08 | |||
US3133132A | 1964-05-12 | |||
US3865108A | 1975-02-11 | |||
US4002173A | 1977-01-11 | |||
US4207893A | 1980-06-17 | |||
US2799241A | 1957-07-16 | |||
US3916899A | 1975-11-04 | |||
US4088864A | 1978-05-09 |
Other References:
"Leading Edge Technologies for Oral Delivery of Poorly Soluble Drugs", 30 November 2015, CMC PUBLISHING, JP, ISBN: 978-4-7813-1169-2, article KAWAKAMI, KOHSAKU: "2.2 The status quo of the selection process", pages: 68 - 73, XP009534562
"Control and Assessment of Pharmaceutical Solid Polymorphism", 30 November 2010, CMC PUBLISHING CO., LTD., JP, ISBN: 978-4-7813-0519-6, article KAWAKAMI, KOHSAKU: "1.7 Microscopic pH change due to salt", pages: 98 - 99, XP009534563
"Control and Assessment of Pharmaceutical Solid Polymorphism", 30 November 2010, CMC PUBLISHING CO., LTD., JP, ISBN: 978-4-7813-0519-6, article KAWAKAMI, KOHSAKU: "1.7 Microscopic pH change due to salt", pages: 98 - 99, XP009534563
Attorney, Agent or Firm:
SAEGUSA & PARTNERS (JP)
Download PDF:
Previous Patent: ORAL PHARMACEUTICAL COMPOSITION
Next Patent: BILIARY ATRESIA DIAGNOSIS SUPPORT MANAGEMENT SYSTEM
Next Patent: BILIARY ATRESIA DIAGNOSIS SUPPORT MANAGEMENT SYSTEM